Literature DB >> 27275496

Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma.

Francesco Feo1, Maria M Simile1, Rosa M Pascale1.   

Abstract

Entities:  

Year:  2016        PMID： 27275496      PMCID： PMC4876269          DOI： 10.21037/atm.2016.03.47

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

2.  Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer.

Authors:  Seung-Mo Hong; Audrey Vincent; Mitsuro Kanda; Julie Leclerc; Noriyuki Omura; Michael Borges; Alison P Klein; Marcia Irene Canto; Ralph H Hruban; Michael Goggins
Journal:  Clin Cancer Res       Date:  2012-06-21       Impact factor: 12.531

Review 3.  Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.

Authors:  Maddalena Frau; Fiorella Biasi; Francesco Feo; Rosa M Pascale
Journal:  Mol Aspects Med       Date:  2010-02-20

Review 4.  Long antisense non-coding RNAs and the epigenetic regulation of gene expression.

Authors:  Nadia Vadaie; Kevin V Morris
Journal:  Biomol Concepts       Date:  2013-08

5.  DNA secondary structures and epigenetic determinants of cancer genome evolution.

Authors:  Subhajyoti De; Franziska Michor
Journal:  Nat Struct Mol Biol       Date:  2011-07-03       Impact factor: 15.369

Review 6.  Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Alessandro Granito; Sara Marinelli; Giulia Negrini; Saverio Menetti; Francesca Benevento; Luigi Bolondi
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

7.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.

Authors:  Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

8.  Genetic regulators of large-scale transcriptional signatures in cancer.

Authors:  Adam S Adler; Meihong Lin; Hugo Horlings; Dimitry S A Nuyten; Marc J van de Vijver; Howard Y Chang
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

9.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors:  Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

10.  Heat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.

Authors:  Pei-Ming Yang; Ming-Heng Wu; Chi-Chen Huang; Chun-Yu Kao; Yi-Chao Lee; Kuen-Haur Lee
Journal:  PeerJ       Date:  2016-02-11       Impact factor: 2.984
View more
  3 in total

1.  Assessment of the Biological Activities of Egyptian Purslane (Portulaca oleracea) Extract after Incorporating Metal Nanoparticles, in Vitro and in Vivo Study.

Authors:  Wael Mahmoud Aboulthana; Nagwa Ibrahim Omar; Enas Ahmed Hasan; Kawkab A Ahmed; Ahmed Mahmoud Youssef
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

Review 2.  Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.

Authors:  Aya El Khodiry; Menna Afify; Hend M El Tayebi
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

3.  The long non-coding RNA AK023948 enhances tumor progression in hepatocellular carcinoma.

Authors:  Bailiang Ye; Bingren Hu; Zhihai Zheng; Ru Zheng; Yixiong Shi
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.